These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9627165)

  • 1. Molecular mechanisms of sepsis.
    Woltmann A; Hamann L; Ulmer AJ; Gerdes J; Bruch HP; Rietschel ET
    Langenbecks Arch Surg; 1998 Mar; 383(1):2-10. PubMed ID: 9627165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemistry, molecular mechanism of action and biological effects of endotoxin].
    Burgmann H; Breyer S
    Wien Med Wochenschr; 1995; 145(9):211-7. PubMed ID: 7543712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Receptors and signal proteins of the innate immune system as new targets in sepsis therapy. Reprogramming of the immune response].
    Holzmann B; Weighardt H; Heidecke CD
    Chirurg; 2003 Jan; 74(1):61-4. PubMed ID: 12552407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Causes of organ failure in infection].
    Bartels H; Stadler J; Barthlen W; Miedtke T; Siewert JR
    Zentralbl Chir; 1994; 119(3):168-74. PubMed ID: 8178582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of early endotoxin tolerance with atoxic endotoxin--a new method for preventing sepsis syndrome].
    Staubach KH; Weber H; Brade H; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1067-70. PubMed ID: 9931792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of endotoxin shock and endotoxin hypersensitivity.
    Galanos C; Freudenberg MA
    Immunobiology; 1993 Apr; 187(3-5):346-56. PubMed ID: 8330903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome.
    Strutz F; Heller G; Krasemann K; Krone B; Müller GA
    Intensive Care Med; 1999 May; 25(5):435-44. PubMed ID: 10401935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms and pathological consequences of endotoxin tolerance and priming.
    Morris M; Li L
    Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):13-8. PubMed ID: 22143158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
    Van Amersfoort ES; Van Berkel TJ; Kuiper J
    Clin Microbiol Rev; 2003 Jul; 16(3):379-414. PubMed ID: 12857774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the boundaries of systemic inflammation*.
    Elinoff JM; Suffredini AF
    Crit Care Med; 2014 Jul; 42(7):1735-7. PubMed ID: 24933053
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2002; 114 Suppl 1():9-19. PubMed ID: 15503552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcompartmental inflammatory responses in humans: IV versus endobronchial administration of endotoxin*.
    Plovsing RR; Berg RM; Evans KA; Konge L; Iversen M; Garred P; Møller K
    Crit Care Med; 2014 Jul; 42(7):1658-65. PubMed ID: 24732241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
    Talan DA
    Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.
    Pollack M; Ohl CA
    Curr Top Microbiol Immunol; 1996; 216():275-97. PubMed ID: 8791745
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early endotoxin tolerance--a preventive concept against infection].
    Staubach KH; Jonas S; Kooistra A; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():360-3. PubMed ID: 9101876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin as a drug target.
    Opal SM; Glück T
    Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection.
    Marsh CB; Wewers MD
    Clin Chest Med; 1996 Jun; 17(2):183-97. PubMed ID: 8792060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.